{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:03:31Z","timestamp":1794351811782,"version":"4.9.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>The aim of this review is to evaluate recent literature surrounding the impact of new medical and surgical therapies for benign prostatic hyperplasia (BPH) on sexual health and function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Recent randomized controlled trials evaluating patients treated with Optilume, Rezum, Urolift, iTind, and prostatic artery embolism reported minimal associated risks for the development of sexual dysfunction. However, these treatments provide inferior improvement in lower urinary tract symptoms (LUTS) when compared to transurethral resection of the prostate (TURP) and simple prostatectomy. Aquablation demonstrates similar improvement in LUTS while significantly minimizing ejaculatory dysfunction compared to TURP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Management of BPH must include patient counseling on the potential risks of sexual dysfunction associated with both medical and surgical therapies. Future research should be guided towards comparing minimally invasive surgical therapies to one another and collecting long-term data on the durability of these therapies on urinary and sexual function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11934-025-01279-z","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T16:24:33Z","timestamp":1749486273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health"],"prefix":"10.1007","volume":"26","author":[{"given":"Danish","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tivoli","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Burnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Raheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Hellstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"1","key":"1279_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12894-024-01582-w","volume":"24","author":"Z Ye","year":"2024","unstructured":"Ye Z, Wang J, Xiao Y, et al. Global burden of benign prostatic hyperplasia in males aged 60\u201390 years from 1990 to 2019: results from the global burden of disease study 2019. BMC Urol. 2024;24(1):193. https:\/\/doi.org\/10.1186\/s12894-024-01582-w.","journal-title":"BMC Urol"},{"key":"1279_CR2","unstructured":"Urologic Diseases in America. 2024 UDA Data Report: Epidemiology of Non-Malignant Urologic Disease in the United States. 2024."},{"issue":"2","key":"1279_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/0970-1591.127856","volume":"30","author":"MJ Speakman","year":"2014","unstructured":"Speakman MJ, Cheng X. Management of the complications of BPH\/BOO. Indian J Urol. 2014;30(2):208\u201313. https:\/\/doi.org\/10.4103\/0970-1591.127856.","journal-title":"Indian J Urol"},{"issue":"4","key":"1279_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/bju.14813","volume":"124","author":"A Kessler","year":"2019","unstructured":"Kessler A, Sollie S, Challacombe B, et al. The global prevalence of erectile dysfunction: a review. BJU Int. 2019;124(4):587\u201399. https:\/\/doi.org\/10.1111\/bju.14813.","journal-title":"BJU Int"},{"issue":"Supp 1","key":"1279_CR5","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1038\/sj.ijir.3900804","volume":"14","author":"CC Carson","year":"2002","unstructured":"Carson CC. Erectile dysfunction in the 21st century: Whom we can treat, whom we cannot treat and patient education. Int J Impot Res. 2002;14(Supp 1):S29\u201334. https:\/\/doi.org\/10.1038\/sj.ijir.3900804.","journal-title":"Int J Impot Res"},{"issue":"4S","key":"1279_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s0022-5347(18)31182-0","volume":"177","author":"RC Rosen","year":"2007","unstructured":"Rosen RC, Seftel AD, Wei JT, et al. 954: Effect of Benign Prostatic Hyperplasia Management on Ejaculatory Function: Longitudinal Data from the BPH Registry & Patient Survey. J Urol. 2007;177(4S):315. https:\/\/doi.org\/10.1016\/s0022-5347(18)31182-0.","journal-title":"J Urol."},{"issue":"4","key":"1279_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s11255-008-9386-z","volume":"40","author":"A Ozayar","year":"2008","unstructured":"Ozayar A, Zumrutbas AE, Yaman O. The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH. Int Urol Nephrol. 2008;40(4):933\u20139. https:\/\/doi.org\/10.1007\/s11255-008-9386-z.","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"1279_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","volume":"44","author":"R Rosen","year":"2003","unstructured":"Rosen R, Altwein J, Boyle P, et al. Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7). Eur Urol. 2003;44(6):637\u201349. https:\/\/doi.org\/10.1016\/j.eururo.2003.08.015.","journal-title":"Eur Urol"},{"issue":"9","key":"1279_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/j.1464-410X.2005.05831.x","volume":"96","author":"MK Li","year":"2005","unstructured":"Li MK, Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: A survey of ageing men from five Asian countries. BJU Int. 2005;96(9):1339\u201354. https:\/\/doi.org\/10.1111\/j.1464-410X.2005.05831.x.","journal-title":"BJU Int"},{"issue":"2","key":"1279_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4306\/pi.2015.12.2.268","volume":"12","author":"JS Koh","year":"2015","unstructured":"Koh JS, Ko HJ, Wang SM, et al. The relationship between depression, anxiety, somatization, personality and symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Psychiatry Investig. 2015;12(2):268\u201373. https:\/\/doi.org\/10.4306\/pi.2015.12.2.268.","journal-title":"Psychiatry Investig"},{"issue":"2","key":"1279_CR11","first-page":"250","volume":"11","author":"F Richard","year":"2001","unstructured":"Richard F, Lukacs B, Jardin A, et al. Results of an epidemiologic surgery carried out with men 50\u201380 years of age to study urinary disorders, quality of life and sexual function. Prog Urol. 2001;11(2):250\u201363.","journal-title":"Prog Urol"},{"issue":"10","key":"1279_CR12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/0895-4356(96)00213-2","volume":"49","author":"GJ Macfarlane","year":"1996","unstructured":"Macfarlane GJ, Botto H, Sagnier PP, et al. The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol. 1996;49(10):1171\u20136. https:\/\/doi.org\/10.1016\/0895-4356(96)00213-2.","journal-title":"J Clin Epidemiol"},{"key":"1279_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0090-4295(98)00054-5","volume":"51","author":"P Narayan","year":"1998","unstructured":"Narayan P, Tewari A. Overview of \u03b2-blocker therapy for benign prostatic hyperplasia. 1998. Urology. 1998;51:38\u201345.","journal-title":"Urology"},{"issue":"1","key":"1279_CR14","doi-asserted-by":"publisher","first-page":"11116","DOI":"10.1038\/s41598-024-61977-5","volume":"14","author":"BT Yoosuf","year":"2024","unstructured":"Yoosuf BT, Panda AK, Kt MF, et al. Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis. Sci Rep. 2024;14(1):11116.","journal-title":"Sci Rep"},{"key":"1279_CR15","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2006.06.004","volume":"176","author":"WJ Hellstrom","year":"2006","unstructured":"Hellstrom WJ, Sikka SC. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol. 2006;176:1529\u201333. https:\/\/doi.org\/10.1016\/j.juro.2006.06.004.","journal-title":"J Urol"},{"key":"1279_CR16","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/j.1442-2042.2006.01535.x","volume":"13","author":"S Hisasue","year":"2006","unstructured":"Hisasue S, Furuya R, Itoh N, et al. Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission. Int J Urol. 2006;13:1311\u20136. https:\/\/doi.org\/10.1111\/j.1442-2042.2006.01535.x.","journal-title":"Int J Urol"},{"issue":"2","key":"1279_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4081\/aiua.2022.2.252","volume":"94","author":"R Bapir","year":"2022","unstructured":"Bapir R, Bhatti KH, Eliwa A, et al. Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis. Arch Ital Urol Androl. 2022;94(2):252\u201363. https:\/\/doi.org\/10.4081\/aiua.2022.2.252.","journal-title":"Arch Ital Urol Androl"},{"issue":"3","key":"1279_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00345-019-02806-7","volume":"38","author":"GS Bhat","year":"2020","unstructured":"Bhat GS, Shastry A. A prospective double-blind, randomized, placebo-controlled study to evaluate the efficacy of silodosin 8 mg as an on-demand, reversible, nonhormonal oral contraceptive for males: a pilot study. W J Urol. 2020;38(3):747\u201351. https:\/\/doi.org\/10.1007\/s00345-019-02806-7.","journal-title":"W J Urol"},{"issue":"1","key":"1279_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.urology.2013.03.026","volume":"82","author":"A Shelbaia","year":"2013","unstructured":"Shelbaia A, Elsaied WM, Elghamrawy H, et al. Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Urology. 2013;82(1):130\u20135. https:\/\/doi.org\/10.1016\/j.urology.2013.03.026.","journal-title":"Urology"},{"issue":"5","key":"1279_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/sj.ijir.3901554","volume":"19","author":"R Rosen","year":"2007","unstructured":"Rosen R, Seftel A, Roehrborn CG. Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia. Int J Impot Res. 2007;19(5):480\u20135. https:\/\/doi.org\/10.1038\/sj.ijir.3901554.","journal-title":"Int J Impot Res"},{"key":"1279_CR21","doi-asserted-by":"publisher","first-page":"530121","DOI":"10.1155\/2012\/530121","volume":"2012","author":"F Azzouni","year":"2012","unstructured":"Azzouni F, Godoy A, Li Y, et al. The 5 alpha-reductase isozyme family: A review of basic biology and their role in human diseases. Adv Urol. 2012;2012:530121. https:\/\/doi.org\/10.1155\/2012\/530121.","journal-title":"Adv Urol"},{"key":"1279_CR22","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1111\/j.1743-6109.2008.01001.x","volume":"5","author":"F Erdemir","year":"2008","unstructured":"Erdemir F, Harbin A, Hellstrom WJG. 5-alpha reductase inhibitors and erectile dysfunction: The connection. J Sex Med. 2008;5:2917\u201324.","journal-title":"J Sex Med"},{"issue":"1","key":"1279_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11934-014-0441-2","volume":"15","author":"C Welliver","year":"2014","unstructured":"Welliver C, Butcher M, Potini Y, et al. Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function topical collection on benign prostatic hyperplasia. Curr Urol Rep. 2014;15(1):441. https:\/\/doi.org\/10.1007\/s11934-014-0441-2.","journal-title":"Curr Urol Rep"},{"key":"1279_CR24","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jsxm.2016.07.006","volume":"13","author":"L Liu","year":"2016","unstructured":"Liu L, Zhao S, Li F, et al. Effect of 5\u03b1-reductase inhibitors on sexual function: A meta-analysis and systematic review of randomized controlled trials. J Sex Med. 2016;13:1297\u2013310. https:\/\/doi.org\/10.1016\/j.jsxm.2016.07.006.","journal-title":"J Sex Med"},{"key":"1279_CR25","first-page":"12","volume":"99","author":"S Lee","year":"2018","unstructured":"Lee S, Lee YB, Choe SJ, et al. Adverse sexual effects of treatment with finasteride or dutasteride for male androgenetic alopecia: A systematic review and meta-analysis. Acta Derm Venereol. 2018;99:12\u20137.","journal-title":"Acta Derm Venereol"},{"key":"1279_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol. 2024;211:11\u20139.","journal-title":"J Urol"},{"key":"1279_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4065\/84.2.139","volume":"84","author":"A Nehra","year":"2009","unstructured":"Nehra A. Erectile dysfunction and cardiovascular disease: Efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions. Mayo Clin Proc. 2009;84:139\u201348. https:\/\/doi.org\/10.4065\/84.2.139.","journal-title":"Mayo Clin Proc"},{"key":"1279_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/j.1939-4640.2002.tb02332.x","volume":"23","author":"WJG Hellstrom","year":"2002","unstructured":"Hellstrom WJG, Gittelman M, Karlin G, et al. Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl. 2002;23:763\u201371. https:\/\/doi.org\/10.1002\/j.1939-4640.2002.tb02332.x.","journal-title":"J Androl"},{"issue":"6","key":"1279_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/jsm.12499","volume":"11","author":"H Yan","year":"2014","unstructured":"Yan H, Zong H, Cui Y, et al. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: A systematic review and meta-analysis. J Sex Med. 2014;11(6):1539\u201345. https:\/\/doi.org\/10.1111\/jsm.12499.","journal-title":"J Sex Med"},{"issue":"6","key":"1279_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11934-013-0373-2","volume":"14","author":"C Lythgoe","year":"2013","unstructured":"Lythgoe C, McVary KT. The use of PDE-5 inhibitors in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Curr Urol Rep. 2013;14(6):585\u201394.","journal-title":"Curr Urol Rep"},{"issue":"1","key":"1279_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/jsm.12714","volume":"12","author":"S Glina","year":"2015","unstructured":"Glina S, Roehrborn CG, Esen A, et al. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride. J Sex Med. 2015;12(1):129\u201338.","journal-title":"J Sex Med"},{"issue":"2","key":"1279_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1056\/NEJM199501123320202","volume":"332","author":"JH Wasson","year":"1995","unstructured":"Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med. 1995;332(2):75\u20139. https:\/\/doi.org\/10.1056\/NEJM199501123320202.","journal-title":"N Engl J Med"},{"issue":"9","key":"1279_CR33","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s11255-018-1950-6","volume":"50","author":"A El-Assmy","year":"2018","unstructured":"El-Assmy A, ElShal AM, Mekkawy R, et al. Erectile and ejaculatory function changes following bipolar versus monopolar transurethral resection of the prostate: A prospective randomized study. Int Urol Nephrol. 2018;50(9):1569\u201376. https:\/\/doi.org\/10.1007\/s11255-018-1950-6.","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"1279_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.eururo.2007.01.088","volume":"52","author":"M Muntener","year":"2007","unstructured":"Muntener M, Aellig S, Kuettel R, et al. Sexual function after transurethral resection of the prostate (TURP): Results of an independent prospective multicenter assessment of outcome. Eur Urol. 2007;52(2):510\u20135.","journal-title":"Eur Urol"},{"issue":"1","key":"1279_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1464-410X.2012.11662.x","volume":"112","author":"C Mamoulakis","year":"2013","unstructured":"Mamoulakis C, Skolarikos A, Schulze M, et al. Bipolar vs monopolar transurethral resection of the prostate: Evaluation of the impact on overall sexual function in an international randomized controlled trial setting. BJU Int. 2013;112(1):109\u201320.","journal-title":"BJU Int"},{"issue":"1","key":"1279_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.afju.2012.04.007","volume":"18","author":"O Abd-El Kader","year":"2012","unstructured":"Abd-El Kader O, El Den KM, El Nashar A, et al. Transurethral incision versus transurethral resection of the prostate in small prostatic adenoma: Long-term follow-up. Afr J Urol. 2012;18(1):29\u201333.","journal-title":"Afr J Urol"},{"issue":"1","key":"1279_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3329\/bju.v24i1.59443","volume":"24","author":"MN Alam","year":"2021","unstructured":"Alam MN, Debnath R, Ahmed M, et al. Outcome of Unilateral Bladder Neck Incision In Comparison to Bilateral Incision in Case of Primary Bladder Neck Obstruction. Bangladesh J Urol. 2021;24(1):46\u201352.","journal-title":"Bangladesh J Urol"},{"issue":"4","key":"1279_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1464-410X.1994.tb07612.x","volume":"73","author":"JM Gil-Vernet Jr","year":"1994","unstructured":"Gil-Vernet JM Jr, Alvarez-Vijande R, Gil-Vernet A, et al. Ejaculation in men: A dynamic endorectal ultrasonographical study. Br J Urol. 1994;73(4):442\u20138.","journal-title":"Br J Urol"},{"issue":"1","key":"1279_CR39","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00345-024-05276-8","volume":"42","author":"A Ramachandran","year":"2024","unstructured":"Ramachandran A, Chavannavar KM, Thiruvengadam G, et al. Ejaculation preserving TURP (Ep-TURP): A viable alternative in sexually active males with BOO\u2014a single-centre prospective randomized study. World J Urol. 2024;42(1):567. https:\/\/doi.org\/10.1007\/s00345-024-05276-8.","journal-title":"World J Urol"},{"issue":"5","key":"1279_CR40","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0022-5347(05)00983-3","volume":"175","author":"A Briganti","year":"2006","unstructured":"Briganti A, Naspro R, Gallina A, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: Results of a prospective, 2-center, randomized trial. J Urol. 2006;175(5):1817\u201321. https:\/\/doi.org\/10.1016\/S0022-5347(05)00983-3.","journal-title":"J Urol"},{"issue":"9","key":"1279_CR41","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/pros.24697","volume":"84","author":"C Roper","year":"2024","unstructured":"Roper C, Slade A, Caras R, et al. Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate. Prostate. 2024;84(9):791\u20136. https:\/\/doi.org\/10.1002\/pros.24697.","journal-title":"Prostate"},{"issue":"11","key":"1279_CR42","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1007\/s00345-022-04175-0","volume":"40","author":"M Deslandes","year":"2022","unstructured":"Deslandes M, Klein C, Marquette T, et al. Influence of holmium laser enucleation of the prostate on erectile function: Results of a multicentric analysis of 235 patients. World J Urol. 2022;40(11):2747\u201354. https:\/\/doi.org\/10.1007\/s00345-022-04175-0.","journal-title":"World J Urol"},{"issue":"3","key":"1279_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1089\/end.2014.0502","volume":"29","author":"J Placer","year":"2015","unstructured":"Placer J, Salvador C, Planas J, et al. Effects of holmium laser enucleation of the prostate on sexual function. J Endourol. 2015;29(3):332\u20139. https:\/\/doi.org\/10.1089\/end.2014.0502.","journal-title":"J Endourol"},{"issue":"1","key":"1279_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00345-022-04201-1","volume":"41","author":"G Bozzini","year":"2023","unstructured":"Bozzini G, Berti L, Maltagliati M, et al. Thulium: YAG vs continuous-wave thulium fiber laser enucleation of the prostate: Do potential advantages of thulium fiber lasers translate into relevant clinical differences? World J Urol. 2023;41(1):143\u201350. https:\/\/doi.org\/10.1007\/s00345-022-04201-1.","journal-title":"World J Urol"},{"issue":"1","key":"1279_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00345-024-05438-8","volume":"43","author":"Z Gao","year":"2025","unstructured":"Gao Z, Wang P, Liu H, et al. Technological innovation of HoLEP: A multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. World J Urol. 2025;43(1):64. https:\/\/doi.org\/10.1007\/s00345-024-05438-8.","journal-title":"World J Urol"},{"issue":"3","key":"1279_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41391-023-00730-x","volume":"27","author":"H Elmansy","year":"2024","unstructured":"Elmansy H, Abbas L, Fathy M, et al. Top-down holmium laser enucleation of the prostate (HoLEP) versus traditional HoLEP for the treatment of benign prostatic hyperplasia (BPH): 1-year outcomes of a randomized controlled trial. Prostate Cancer Prostatic Dis. 2024;27(3):462\u20138. https:\/\/doi.org\/10.1038\/s41391-023-00730-x.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"1279_CR47","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00345-024-05315-4","volume":"42","author":"RS Titus","year":"2024","unstructured":"Titus RS, Bhatia A, Porto JG, et al. Open simple prostatectomy in the last three decades: Results of a meta-analysis. World J Urol. 2024;42(1):625. https:\/\/doi.org\/10.1007\/s00345-024-05315-4.","journal-title":"World J Urol"},{"key":"1279_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.urology.2024.04.024","volume":"189","author":"BR Lebani","year":"2024","unstructured":"Lebani BR, Porto DDS, Silva ABD, et al. Randomized controlled trial comparing open simple prostatectomy or prostate artery embolization in large prostates: Clinical and urodynamic assessment\u2014PoPAE study. Urology. 2024;189:94\u2013100. https:\/\/doi.org\/10.1016\/j.urology.2024.04.024.","journal-title":"Urology"},{"issue":"2","key":"1279_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11701-022-01460-3","volume":"17","author":"KP Li","year":"2023","unstructured":"Li KP, Chen SY, Yang L. Laparoscopic simple prostatectomy versus robot-assisted simple prostatectomy for large benign prostatic hyperplasia: A systematic review and meta-analysis of comparative trials. J Robotic Surg. 2023;17(2):351\u201364. https:\/\/doi.org\/10.1007\/s11701-022-01460-3.","journal-title":"J Robotic Surg"},{"issue":"6","key":"1279_CR50","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/s0022-5347(17)39753-7","volume":"144","author":"AR Dixon","year":"1990","unstructured":"Dixon AR, Lord PH, Madigan MR. The Madigan prostatectomy. J Urol. 1990;144(6):1401\u20133. https:\/\/doi.org\/10.1016\/s0022-5347(17)39753-7.","journal-title":"J Urol"},{"issue":"2","key":"1279_CR51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.eururo.2020.09.028","volume":"80","author":"F Porpiglia","year":"2021","unstructured":"Porpiglia F, Checcucci E, Amparore D, et al. Urethral-sparing robot-assisted simple prostatectomy: An innovative technique to preserve ejaculatory function overcoming the limitation of the standard Millin approach. Eur Urol. 2021;80(2):222\u201333. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.028.","journal-title":"Eur Urol"},{"key":"1279_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00923-y","author":"M Pacini","year":"2024","unstructured":"Pacini M, Lambertini L, Avesani G, et al. Single-port transvesical simple prostatectomy for the surgical treatment of benign prostatic hyperplasia: Functional and continence outcomes. Prostate Cancer Prostatic Dis. 2024. https:\/\/doi.org\/10.1038\/s41391-024-00923-y.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"1279_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/UPJ.0000000000000691","volume":"12","author":"HV Patel","year":"2025","unstructured":"Patel HV, Breyer BN, Jones C, et al. Contemporary trends of benign prostatic hyperplasia procedures in the AUA Quality Registry: Are we moving the needle toward more minimally invasive treatments? Urol Pract. 2025;12(1):124\u20139. https:\/\/doi.org\/10.1097\/UPJ.0000000000000691.","journal-title":"Urol Pract"},{"issue":"3","key":"1279_CR54","first-page":"8802","volume":"24","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG, Barkin J, Gange SN, et al. Five-year results of the prospective randomized controlled prostatic urethral LIFT study. Can J Urol. 2017;24(3):8802\u201313.","journal-title":"Can J Urol"},{"issue":"5","key":"1279_CR55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/bju.13714","volume":"119","author":"C Gratzke","year":"2017","unstructured":"Gratzke C, Barber N, Speakman MJ, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int. 2017;119(5):767\u201375. https:\/\/doi.org\/10.1111\/bju.13714.","journal-title":"BJU Int"},{"issue":"5","key":"1279_CR56","first-page":"10824","volume":"28","author":"D Elterman","year":"2021","unstructured":"Elterman D, Shepherd S, Saadat SH, et al. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: A comparison of improvements and durability in 3-year clinical outcomes. Can J Urol. 2021;28(5):10824\u201333.","journal-title":"Can J Urol"},{"issue":"1","key":"1279_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1089\/end.2022.0226","volume":"37","author":"D Elterman","year":"2023","unstructured":"Elterman D, Alshak MN, Martinez Diaz S, Shore N, Gittleman M, Motola J, Pike S, Hermann C, Terens W, Kohan A, Gonzalez R. An evaluation of sexual function in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia in men treated with the temporarily implanted nitinol device. J Endourol. 2023;37(1):74\u20139. https:\/\/doi.org\/10.1089\/end.2022.0226.","journal-title":"J Endourol"},{"key":"1279_CR58","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","volume":"153","author":"B Chughtai","year":"2021","unstructured":"Chughtai B, Elterman D, Shore N, et al. The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A multicenter, randomized, controlled trial. Urology. 2021;153:270\u20136. https:\/\/doi.org\/10.1016\/j.urology.2020.12.022.","journal-title":"Urology"},{"issue":"3","key":"1279_CR59","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/JU.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021;206(3):715\u201324. https:\/\/doi.org\/10.1097\/JU.0000000000001778.","journal-title":"J Urol"},{"key":"1279_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2017.10.023","volume":"111","author":"KT McVary","year":"2018","unstructured":"McVary KT, Roehrborn CG. Three-year outcomes of the prospective, randomized controlled Rez\u016bm system study: Convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology. 2018;111:1\u20139. https:\/\/doi.org\/10.1016\/j.urology.2017.10.023.","journal-title":"Urology"},{"key":"1279_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","volume":"126","author":"KT McVary","year":"2019","unstructured":"McVary KT, Rogers T, Roehrborn CG. Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology. 2019;126:171\u20139. https:\/\/doi.org\/10.1016\/j.urology.2018.12.041.","journal-title":"Urology"},{"issue":"12","key":"1279_CR62","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jsxm.2018.10.006","volume":"15","author":"KT McVary","year":"2018","unstructured":"McVary KT, Rogers T, Mahon J, et al. Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia? J Sex Med. 2018;15(12):1728\u201338. https:\/\/doi.org\/10.1016\/j.jsxm.2018.10.006.","journal-title":"J Sex Med"},{"issue":"1","key":"1279_CR63","first-page":"10960","volume":"29","author":"PJ Gilling","year":"2022","unstructured":"Gilling PJ, Barber N, Bidair M, et al. Five-year outcomes for Aquablation therapy compared to TURP: Results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol. 2022;29(1):10960\u20138.","journal-title":"Can J Urol"},{"issue":"3","key":"1279_CR64","first-page":"9317","volume":"25","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Hussain M. Aquablation versus transurethral resection of the prostate: 1-year United States cohort outcomes. Can J Urol. 2018;25(3):9317\u201322.","journal-title":"Can J Urol"},{"key":"1279_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.urology.2025.01.020","volume":"198","author":"JYC Teoh","year":"2025","unstructured":"Teoh JYC, Yuen SKK, Lau BSY, et al. Robotic waterjet resection for men with prostate cancer suffering from lower urinary tract symptoms. Urology. 2025;198:153\u20137. https:\/\/doi.org\/10.1016\/j.urology.2025.01.020.","journal-title":"Urology"},{"key":"1279_CR66","doi-asserted-by":"publisher","first-page":"100672","DOI":"10.1016\/j.lanepe.2023.100672","volume":"31","author":"M Sapoval","year":"2023","unstructured":"Sapoval M, Thiounn N, Descazeaud A, et al. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): A randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur. 2023;31:100672. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100672.","journal-title":"Lancet Reg Health Eur"},{"issue":"5","key":"1279_CR67","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jvir.2024.01.026","volume":"35","author":"P Goyal","year":"2024","unstructured":"Goyal P, Varadhan AK, Jenkins K, et al. Prostatic artery embolization in patients with refractory lower urinary tract symptoms after a prior minimally invasive surgical treatment. J Vasc Interv Radiol. 2024;35(5):744\u201350. https:\/\/doi.org\/10.1016\/j.jvir.2024.01.026.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"1279_CR68","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00270-025-03966-3","volume":"48","author":"A Richardson","year":"2025","unstructured":"Richardson A, Bhatia A, Maini A, et al. Impact on sexual function of protective coil embolization of penile collaterals during prostatic artery embolization. Cardiovasc Intervent Radiol. 2025;48(4):512\u201321. https:\/\/doi.org\/10.1007\/s00270-025-03966-3.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"1279_CR69","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/jsxmed\/qdae206","volume":"22","author":"O Copelan","year":"2025","unstructured":"Copelan O, Moss J, Freedman S, et al. Preservation of sexual function with Optilume\u2014a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med. 2025;22(3):446\u201353. https:\/\/doi.org\/10.1093\/jsxmed\/qdae206.","journal-title":"J Sex Med"},{"issue":"10","key":"1279_CR0","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jsxm.2020.07.006","volume":"17","author":"D Bouhadana","year":"2020","unstructured":"Bouhadana D, Nguyen DD, Zorn KC, et al. Patient Perspectives on Benign Prostatic Hyperplasia Surgery: A Focus on Sexual Health. J Sex Med. 2020;17(10):2108\u201312. https:\/\/doi.org\/10.1016\/j.jsxm.2020.07.006.","journal-title":"J Sex Med"},{"key":"1279_CR71","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199210223271701","volume":"327","author":"GJ Gormley","year":"1992","unstructured":"Gormley GJ, Stoner E, Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia The Finasteride Study Group. N Engl J Med. 1992;327:1185\u201391.","journal-title":"N Engl J Med"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01279-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-025-01279-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01279-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:04:02Z","timestamp":1767985442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-025-01279-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1007\/s11934-025-01279-z","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"2 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any relevant disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Rights and Animal Rights"}},{"value":"Dr. Omer Raheem is the Section Editor of Current Urology Reports.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"49"}}